Lexicon Pharmaceuticals, a pharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) for its heart failure…
FDA Advisers Evaluate Sarepta’s Duchenne Gene Therapy
FDA advisers are currently undertaking a careful evaluation of Sarepta’s Duchenne gene therapy, a groundbreaking treatment that holds immense potential…